Bioanalytical Systems to Release Second Quarter Fiscal 2019 Results on Wednesday, May 15, 2019
May 10 2019 - 8:33AM
Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the
“Company”) today announced that it will report financial results
for the second quarter of fiscal 2019 ended March 31, 2019, prior
to the market opening on Wednesday, May 15, 2019. If there are any
questions after the press release is issued, please direct your
comments to the investor relations contact noted in this release.
About Bioanalytical Systems, Inc.
BASi is a pharmaceutical development company providing contract
research services and monitoring instruments to emerging
pharmaceutical companies and the world's leading drug development
companies and medical research organizations. The Company focuses
on developing innovative services supporting its clients’ discovery
and development objectives for improved decision-making and
accelerated goal attainment. BASi products focus on increasing
efficiency, improving data, and reducing the cost of taking new
drugs to market. Visit www.BASinc.com for more
information about BASi.
This release may contain forward-looking statements that are
subject to risks and uncertainties including, but not limited to,
risks and uncertainties related to changes in the market and demand
for our products and services, the development, marketing and sales
of products and services, changes in technology, industry and
regulatory standards, and various market and operating risks
detailed in the company's filings with the U.S. Securities and
Exchange Commission.
FOR MORE INFORMATION:
Company Contact:Jill C.
BlumhoffChief Financial OfficerPhone:
765.497.8381jblumhoff@BASinc.com
Bioanalytical Systems (NASDAQ:BASI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bioanalytical Systems (NASDAQ:BASI)
Historical Stock Chart
From Apr 2023 to Apr 2024